In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.
about
SARS: systematic review of treatment effectsRespiratory viruses other than influenza virus: impact and therapeutic advancesSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionStructure and inhibition of the SARS coronavirus envelope protein ion channelA review of treatment modalities for Middle East Respiratory Syndrome.Baicalein, Ethyl Acetate, and Chloroform Extracts of Scutellaria baicalensis Inhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A Viruses.Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection.Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitroThe emergence of the Middle East respiratory syndrome coronavirusCoronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelSevere acute respiratory syndrome (SARS): lessons learnt in Hong KongDesign, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion in the study of anemoside B4, a novel antiviral agent candidate, in rats.Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.Antiviral activity of Carbenoxolone disodium against dengue virus infection.San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E.Optimization of the extraction of total flavonoids from Scutellaria baicalensis Georgi using the response surface methodology.Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities.A fatal case of Ludwig's angina and mediastinitis caused by an unusual microorganism, Gemella morbillorum.Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.Severe acute respiratory syndrome
P2860
Q21144696-EF9C5243-DC2A-4523-9034-3B12235697D4Q24655957-5C688FDE-5BB9-4C78-BA4B-8484E4D29798Q28383088-FE39FBBB-A646-4E73-84BB-74A7B597CFA0Q28475712-B5412F17-A98A-404C-9AB6-229460807FDAQ30248209-5A7D959A-7098-4848-9609-F962E3CDD8CCQ30352178-9B76F342-2C23-4156-A262-4A023401EB92Q30429521-D925DFD8-239A-40D1-A76A-9D13BB3DE8B0Q33427270-FAC185C4-C38B-4A61-AC66-32EA43FA22CAQ33868614-723C005F-B5FD-49C4-9324-A1AF5BB8B433Q33934034-976542E1-A668-4D8A-B2F2-EDD1AFD76E02Q34193942-21BABEEF-9C4F-48DE-A37B-E10C9FF86EDEQ34478750-DC955C91-DB32-4BAA-B520-5018D3A49E5CQ34974298-A06B11AF-7DF8-4C08-BFC3-26E2931E7363Q35739055-EE6314DC-1C40-4186-BAC3-74B774215ED2Q36140676-013C16D4-899E-430A-A6D9-8B01CB4085E7Q36221394-333937C0-4DC1-4740-A95A-679A8B5D2C5FQ37481314-C2A6283E-8E65-43E9-BA8C-D0F6908912A0Q39370376-663E07ED-56CC-47F6-A108-D73E95652615Q39520749-EE5BADC1-1BB5-4D26-9513-7B81DBC51C52Q40429766-7609C437-1645-471F-907C-25455FB32D1EQ42068978-9CAC7735-8584-4BA9-B21B-F0FCFCD5C09CQ43565625-5EB33D33-6A28-427D-91E0-87501FCF0DD4Q44665628-9BB4FD4D-13B9-450F-A57E-EACF22CFA87DQ50572228-31C16F72-69E0-44D1-8D62-EF7EE0856120Q56775278-D6D4BC09-52AE-498F-9FD2-C310329EA2DB
P2860
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
In vitro susceptibility of 10 ...... selected antiviral compounds.
@en
type
label
In vitro susceptibility of 10 ...... selected antiviral compounds.
@en
prefLabel
In vitro susceptibility of 10 ...... selected antiviral compounds.
@en
P2093
P50
P1476
In vitro susceptibility of 10 ...... o selected antiviral compounds
@en
P2093
P356
10.1016/J.JCV.2004.03.003
P577
2004-09-01T00:00:00Z